Table 1.

Characteristics of rheumatologists responding to treat-to-target survey (n = 439). Values are % unless otherwise specified.

VariablesPhysicians Who Measure Quantitatively, n = 255Physicians Who Do Not Measure Quantitatively, n = 184p
Physician characteristics and practice patterns
  Age, yrs, mean (SD)56.7 (9.8)57.8 (9.9)0.20
  Male73720.85
  Practice setting, n physicians
    Academic24230.005
    Solo practice1828
    Rheumatology group2915
    Multispecialty group2220
    Other1110
  > 20 RA patients seen per week60540.20
  Yrs in rheumatologic practice
    ≤ 2035330.54
    21–303633
    > 303035
  Use TNF inhibitors for at least 50% of RA patients76660.02
  How many TNF inhibitors must a patient fail before you choose another MOA?
    Exactly 131260.22
    26573
    3+12
    None; non-TNF MOA biologics are my first line12
Beliefs about treating to target and RA patient outcomes
  Doesn’t believe in “treat-to-target hype”1442< 0.01
  What fraction of your RA patients achieve remission?
    < 2020170.90
    20 – < 302020
    30 – < 502424
    ≥ 503739
  What fraction of your RA patients achieve low disease activity?
    < 5025220.73
    50 – < 601413
    60 – < 803235
    ≥ 802931
  • Some column totals may not sum exactly to 100% because of rounding. RA: rheumatoid arthritis; TNF: tumor necrosis factor; MOA: mechanism of action.